815 related articles for article (PubMed ID: 19393644)
21. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations.
Strome SE; Savva A; Brissett AE; Gostout BS; Lewis J; Clayton AC; McGovern R; Weaver AL; Persing D; Kasperbauer JL
Clin Cancer Res; 2002 Apr; 8(4):1093-100. PubMed ID: 11948119
[TBL] [Abstract][Full Text] [Related]
22. Human papilloma virus in squamous carcinoma of the head and neck: a study of cases in south east Scotland.
Anderson CE; McLaren KM; Rae F; Sanderson RJ; Cuschieri KS
J Clin Pathol; 2007 Apr; 60(4):439-41. PubMed ID: 17405984
[TBL] [Abstract][Full Text] [Related]
23. The use of an immunohistochemical diagnostic panel to determine the primary site of cervical lymph node metastases of occult squamous cell carcinoma.
Park JM; Jung CK; Choi YJ; Lee KY; Kang JH; Kim MS; Hu HJ
Hum Pathol; 2010 Mar; 41(3):431-7. PubMed ID: 19954817
[TBL] [Abstract][Full Text] [Related]
24. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
Kraft S; Faquin WC; Krane JF
Am J Surg Pathol; 2012 Mar; 36(3):321-30. PubMed ID: 22301491
[TBL] [Abstract][Full Text] [Related]
25. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases.
Doxtader EE; Katzenstein AL
Hum Pathol; 2012 Mar; 43(3):327-32. PubMed ID: 21840041
[TBL] [Abstract][Full Text] [Related]
26. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience.
Singhi AD; Westra WH
Cancer; 2010 May; 116(9):2166-73. PubMed ID: 20186832
[TBL] [Abstract][Full Text] [Related]
27. Clinical features of human papilloma virus-related head and neck squamous cell carcinoma of an unknown primary site.
Kobayashi K; Saito Y; Omura G; Ando M; Sakamoto T; Yamasoba T; Asakage T
ORL J Otorhinolaryngol Relat Spec; 2014; 76(3):137-46. PubMed ID: 24993345
[TBL] [Abstract][Full Text] [Related]
28. Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung.
Weichert W; Schewe C; Denkert C; Morawietz L; Dietel M; Petersen I
Am J Surg Pathol; 2009 Apr; 33(4):513-20. PubMed ID: 19145203
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters.
Badaracco G; Venuti A; Morello R; Muller A; Marcante ML
Anticancer Res; 2000; 20(2B):1301-5. PubMed ID: 10810439
[TBL] [Abstract][Full Text] [Related]
30. HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome.
Tribius S; Hoffmann AS; Bastrop S; Görögh T; Haag J; Röcken C; Clauditz T; Grob T; Wilczak W; Tennstedt P; Borcherding A; Petersen C; Hoffmann M
Oral Oncol; 2012 Nov; 48(11):1178-84. PubMed ID: 22739067
[TBL] [Abstract][Full Text] [Related]
31. Detection of human papillomavirus (HPV) type 6, 16 and 18 in head and neck squamous cell carcinomas by in situ hybridization.
Cerovac Z; Sarcević B; Kralj Z; Ban J
Neoplasma; 1996; 43(3):185-94. PubMed ID: 8841506
[TBL] [Abstract][Full Text] [Related]
32. Origin of cystic squamous cell carcinoma metastases in head and neck lymph nodes: Addition of EBV testing improves diagnostic accuracy.
Švajdler M; Kašpírková J; Hadravský L; Laco J; Dubinský P; Straka Ľ; Ondič O; Michal M; Skálová A
Pathol Res Pract; 2016 Jun; 212(6):524-31. PubMed ID: 27013059
[TBL] [Abstract][Full Text] [Related]
33. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
Kerr DA; Pitman MB; Sweeney B; Arpin RN; Wilbur DC; Faquin WC
Cancer Cytopathol; 2014 Mar; 122(3):167-74. PubMed ID: 24259368
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus type 16 oropharyngeal cancers in lymph nodes as a marker of metastases.
Mirghani H; Moreau F; Lefèvre M; Tam C; Périé S; Soussan P; St Guily JL
Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):910-4. PubMed ID: 21930979
[TBL] [Abstract][Full Text] [Related]
35. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.
Mork J; Lie AK; Glattre E; Hallmans G; Jellum E; Koskela P; Møller B; Pukkala E; Schiller JT; Youngman L; Lehtinen M; Dillner J
N Engl J Med; 2001 Apr; 344(15):1125-31. PubMed ID: 11297703
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype.
El-Mofty SK; Patil S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):339-45. PubMed ID: 16504868
[TBL] [Abstract][Full Text] [Related]
38. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin.
Begum S; Gillison ML; Ansari-Lari MA; Shah K; Westra WH
Clin Cancer Res; 2003 Dec; 9(17):6469-75. PubMed ID: 14695150
[TBL] [Abstract][Full Text] [Related]
39. Role of cytology in the diagnosis and management of HPV-associated head and neck carcinoma.
Krane JF
Acta Cytol; 2013; 57(2):117-26. PubMed ID: 23406782
[TBL] [Abstract][Full Text] [Related]
40. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
